Modeling the heart defect of transposition of the great arteries using the PHYSBE model

2012 ◽  
Author(s):  
Mohamad Amin Bakhshali ◽  
Sabalan Daneshvar ◽  
Mahsa Mafi
Keyword(s):  
Heart Defect

Congenital heart defect in sibs with discordant karyotypes

1998 ◽  
Vol 80 (2) ◽  
pp. 169-172 ◽  
Author(s):  
Maria Cristina Digilio ◽  
Bruno Marino ◽  
Salvatore A. Canepa ◽  
Umberto Borzaga ◽  
Aldo Giannotti ◽  
...  
Keyword(s):  
Congenital Heart Defect ◽  
Congenital Heart ◽  
Heart Defect

scholarly journals Mountain climbing of the grown-up patient with non-corrected congenital heart defect

2016 ◽  
Vol 1 ◽  
pp. 68-71
Author(s):  
Ireneusz Haponiuk ◽  
Katarzyna Gierat-Haponiuk ◽  
Dominika Szalewska ◽  
Piotr Niedoszytko ◽  
Stanisław Bakuła ◽  
...  
Keyword(s):  
Congenital Heart Defect ◽  
Congenital Heart ◽  
Mountain Climbing ◽  
Heart Defect

scholarly journals How to Predict the Impact of Methylphenidate on Cardiovascular Risk in Children with Attention Deficit Disorder: Methylphenidate Improves Autonomic Dysfunction in Children with ADHD

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Reiner Buchhorn ◽  
Christian Müller ◽  
Christian Willaschek ◽  
Kambiz Norozi
Keyword(s):  
Sudden Cardiac Death ◽  
Attention Deficit ◽  
Attention Deficit Disorder ◽  
Cardiac Death ◽  
Control Group ◽  
Healthy Children ◽  
Children With Adhd ◽  
Heart Defect ◽  
Adhd Children ◽  
The Impact

Background. Although stimulants have long been touted as treatments for attention deficit disorder with or without hyperactivity (ADHD), in recent years, increasing concerns have been raised about the cardiovascular safety of these medications. We aimed to prove if measurements of autonomic function with time domain analysis of heart rate variability (HRV) in 24-hour Holter ECG are useful to predict the risk of sudden cardiac death in ADHD children and adolescents. Methods. We analysed HRV obtained from children with the diagnosis of ADHD prior to (N=12) or during medical therapy (N=19) with methylphenidate (MPH), aged 10.8±2.0 years (mean ± SD), who were referred to our outpatient Paediatric Cardiology Clinic to rule out heart defect. As a control group, we compared the HRV data of 19 age-matched healthy children without heart defect. Results. Average HRV parameters from 24-hour ECG in the ADHD children prior to MPH showed significant lower values compared to healthy children with respect to rMSSD (26±4 ms versus 44±10 ms, P≤0.0001) and pNN50 (6.5±2.7% versus 21.5±9.0%, P≤0.0001). These values improved in MPH-treated children with ADHD (RMSSD: 36±8 ms; pNN50: 14.2±6.9%). Conclusion. Children who suffer from ADHD show significant changes in HRV that predominantly reflects diminished vagal tone, a well-known risk factor of sudden cardiac death in adults. In our pilot study, MPH treatment improved HRV.

Aural atresia, microtia, complex heart defect, and hearing loss syndrome: Additional case

2003 ◽  
Vol 117A (1) ◽  
pp. 83-84 ◽  
Author(s):  
Maria Leine Guion-Almeida ◽  
Nancy Mizue Kokitsu-Nakata
Keyword(s):  
Hearing Loss ◽  
Additional Case ◽  
Aural Atresia ◽  
Heart Defect
Sign in / Sign up

Export Citation Format

Share Document